With over 25 years of experience serving the cancer research community, we are focused on developing the right products, services, and support to meet the unique challenges of cancer genomics research.
With access to these innovative products and platforms, you can uncover the genetic variants and RNA signatures you need to power your next breakthrough.
Identify new biomarkers and develop future tests from NGS analyses of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in serially collected whole-blood research samples.
Laser Capture Microdissection
Isolate pure populations of cancer cells from tumor tissues.
Whole Exome Sequencing
Discover new biomarkers for cancer research using exome sequencing.
Targeted Sequencing for Cancer Mutation Detection
Rapidly screen hundreds of cancer genes with as little as 10 ng of FFPE DNA.
Cancer RNA Expression
Uncover RNA signatures that provide new insights in the identification, characterization, and progression of cancer subtypes.
Cancer Genotyping Assays: Somatic and Germline
Accurately screen or confirm somatic and germline variants of choice using sequencing and real-time PCR.
Identify epigenetic changes that occur during tumor progression.
Cancer Genomics Data Analysis
From gene targets to predictive biomarkers the Oncomine® Platform can answer your cancer research questions.
Learn how Life Technologies solutions are being used to uncover genetic variants across the cancer genome and overcome many of the challenges inherent in working with tumor tissues in the research setting.
|Ion Torrent™ Amplicon Sequencing—
A Tool to Advance Clinical Research
|Rapid innovation and flexibility of the PGM™ and Ion Proton™ Sequencers drives the cancer genome research laboratory into the future|
|Speaker: Dr. Stephen Yip
BC Cancer Agency, Vancouver General Hospital
|Speaker: Dr. Joe Boland
Frederick National Laboratory for Cancer Research SAIC-Frederick
Access scientific posters demonstrating new results and methodologies in cancer genomics from recent scientific conferences.